Neuronal IGF‐1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876

A C. elegans mutant that lives twice as long as wild type

Kenyon, C., Chang, J., Gensch, E., Rudner, A., & Tabtiang, R. (1993) · Nature · doi:10.1038/366461a0 · Cited by 3,387

daf-2 , an Insulin Receptor-Like Gene That Regulates Longevity and Diapause in Caenorhabditis elegans

Kimura, K. D., Tissenbaum, H. A., Liu, Y., & Ruvkun, G. (1997) · Science · doi:10.1126/science.277.5328.942 · Cited by 2,250

Role of Brain Insulin Receptor in Control of Body Weight and Reproduction

Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703

Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?

Gratuze, M., Joly‐Amado, A., Vieau, D., Buée, L., & Blum, D. L. (2018) · Neuroendocrinology · doi:10.1159/000487641 · Cited by 51

Klotho at the Edge of Alzheimer’s Disease and Senile Depression

Paroni, G., Panza, F., Cosmo, S. D., Greco, A., Seripa, D., & Mazzoccoli, G. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1200-z · Cited by 43

Insulin-Like Growth Factor-1 and Central Neurodegenerative Diseases

Torres‐Alemán, I. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.016 · Cited by 43

Genome Instability in Development and Aging: Insights from Nucleotide Excision Repair in Humans, Mice, and Worms

Edifizi, D., & Schumacher, B. (2015) · Biomolecules · doi:10.3390/biom5031855 · Cited by 45

Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics

Avgerinos, K. I., Mullins, R. J., Vreones, M. P., Mustapić, M., Chen, Q., Melvin, D. L., Kapogiannis, D., & Egan, J. M. (2022) · Cells · doi:10.3390/cells11213372 · Cited by 41

The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states

Núñez, Á., Zegarra-Valdivia, J. A., de Sevilla, D. F., Pignatelli, J., & Aleman, I. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02136-6 · Cited by 41

Alzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells

Wojda, U., & Kuźnicki, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121984 · Cited by 40

Neuronal functions of FOXO/DAF-16

Kim, S. Y., & Webb, A. E. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-160009 · Cited by 41

Quality Control Compartments Coming of Age

Ben‐Gedalya, T., & Cohen, E. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01330.x · Cited by 38

Integrating Metabolism and Longevity Through Insulin and IGF1 Signaling

Sadagurski, M., & White, M. F. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.008 · Cited by 39

The Roles of Cellular and Organismal Aging in the Development of Late-Onset Maladies

Marques, F. C., Volovik, Y., & Cohen, E. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040508 · Cited by 38

Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments

Ben‐Gedalya, T., Lyakhovetsky, R., Yedidia, Y., Bejerano‐Sagie, M., Kogan, N. M., Karpuj, M. V., Kaganovich, D., & Cohen, E. (2011) · Journal of Cell Science · doi:10.1242/jcs.077693 · Cited by 36

The nematode Caenorhabditis elegans: A versatile model for the study of proteotoxicity and aging

Volovik, Y., Marques, F. C., & Cohen, E. (2014) · Methods · doi:10.1016/j.ymeth.2014.04.014 · Cited by 36

Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease

Ochiai, T., Sano, T., Nagayama, T., Kubota, N., Kadowaki, T., Wakabayashi, T., & Iwatsubo, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105510 · Cited by 36

Alzheimer's disease‐causing proline substitutions lead to presenilin 1 aggregation and malfunction

Ben‐Gedalya, T., Moll, L., Bejerano‐Sagie, M., Frère, S. G. A., Cabral, W. A., Friedmann‐Morvinski, D., Slutsky, I., Burstyn‐Cohen, T., Marini, J. C., & Cohen, E. (2015) · The EMBO Journal · doi:10.15252/embj.201592042 · Cited by 35

Acute exercise increases circulating IGF-1 in Alzheimer’s disease patients, but not in older adults without dementia

Stein, A. M., da Silva, T. M. V., Coelho, F. G. D. M., Rueda, A. V. L., Camarini, R., & Galduróz, R. F. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112903 · Cited by 37

Caenorhabditis elegans as a model organism to study APP function

Ewald, C. Y., & Li, C. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2905-7 · Cited by 33

IGF/IGF-1R signal pathway in pain: a promising therapeutic target

Ma, L., Zhao, W., Huang, S., Xu, F., Wang, Y., Deng, D., Zhang, T., Shu, S., & Chen, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84353 · Cited by 31

The IGF System and Aging

Conover, C. A., & Oxvig, C. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae029 · Cited by 35

The Role of Insulin and Insulin-Like Growth Factor-1/FoxO-Mediated Transcription for the Pathogenesis of Obesity-Associated Dementia

Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 31

In vivo analysis of gene expression in long-lived mice lacking the pregnancy-associated plasma protein A (PappA) gene

Swindell, W. R., Masternak, M. M., & Bartke, A. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.02.009 · Cited by 28

Reduced insulin signaling maintains electrical transmission in a neural circuit in aging flies

Augustin, H., McGourty, K., Allen, M. J., Kudumala, S., Adcott, J., Kerr, F., Wong, C. T., Vincent, A. J., Godenschwege, T. A., Boucrot, E., et al. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2001655 · Cited by 27

The inhibition of IGF‐1 signaling promotes proteostasis by enhancing protein aggregation and deposition

Moll, L., Ben‐Gedalya, T., Reuveni, H., & Cohen, E. (2015) · The FASEB Journal · doi:10.1096/fj.15-281675 · Cited by 29

When aging-onset diabetes is coming across with Alzheimer disease: Comparable pathogenesis and therapy

Tang, J., Pei, Y., & Zhou, G. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.04.013 · Cited by 28

Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis

Bickel, M. A., Csík, B., Gulej, R., Ungvari, A., Nyúl‐Tóth, Á., & Conley, S. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1087053 · Cited by 28

Royal jelly promotes DAF-16-mediated proteostasis to tolerate β-amyloid toxicity inC. elegansmodel of Alzheimer's disease

Wang, X., Cao, M., & Dong, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10857 · Cited by 28

Early brain amyloidosis in APP/PS1 mice with serum insulin-like growth factor-I deficiency

Poirier, R., Fernandez, A. M., Torres‐Alemán, I., & Metzger, F. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.048 · Cited by 27

The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice

Puig, K. L., Kulas, J. A., Franklin, W. F., Rakoczy, S. G., Taglialatela, G., Brown‐Borg, H. M., & Combs, C. K. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.021 · Cited by 31

Involvement of Insulin-Like Growth Factor 1 Receptor Signaling in the Amyloid-β Peptide Oligomers-Induced p75 Neurotrophin Receptor Protein Expression in Mouse Hippocampus

Ito, S., Ménard, M., Atkinson, T. G., Gaudet, C., Brown, L., Whitfield, J., & Chakravarthy, B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120046 · Cited by 26

Negative Regulation of Grb10 Interacting GYF Protein 2 on Insulin-Like Growth Factor-1 Receptor Signaling Pathway Caused Diabetic Mice Cognitive Impairment

Xie, J., Wei, Q., Deng, H., Li, G., Ma, L., & Zeng, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108559 · Cited by 26

Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?

Fonseca, C., Ettcheto, M., Bicker, J., Fernandes, M. J., Falcão, A. C., Camins, A., & Fortuna, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101998 · Cited by 31

Mitochondrial deficiency: a double-edged sword for aging and neurodegeneration

Troulinaki, K., & Bano, D. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00244 · Cited by 24

Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer’s-like phenotypes in mice

Murakami, K., Yokoyama, S.-I., Murata, N., Ozawa, Y., Irie, K., Shirasawa, T., & Shimizu, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.101 · Cited by 25

Chronic peripheral hyperinsulinemia has no substantial influence on tau phosphorylation in vivo

Becker, K., Freude, S., Zemva, J., Stöhr, O., Krone, W., & Schubert, M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.022 · Cited by 24

Diabetes, Insulin and Alzheimer's Disease

Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24

IGF1 Gene Therapy Modifies Microglia in the Striatum of Senile Rats

Lockhart, E. F., Dolcetti, F. J. C., García‐Segura, L. M., Hereñú, C. B., & Bellini, M. J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00048 · Cited by 23

Insulin signaling and oxidative stress: Bridging the gap between type 2 diabetes mellitus and Alzheimer's disease

Xu, F.-Q., & Shi, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241307404 · Cited by 25

Insulin signaling in Drosophila melanogaster mediates Aβ toxicity

Huang, Y., Wan, Z., Wang, Z., & Zhou, B. (2018) · Communications Biology · doi:10.1038/s42003-018-0253-x · Cited by 23

Disrupting IGF Signaling in Adult Mice Conditions Leanness, Resilient Energy Metabolism, and High Growth Hormone Pulses

François, J., Aïd, S., Chaker, Z., Lacube, P., Xu, J., Fayad, R., Côté, F., Even, P. C., & Holzenberger, M. (2017) · Endocrinology · doi:10.1210/en.2017-00261 · Cited by 22

Insulin Peptides as Mediators of the Impact of Life Style in Alzheimer’s disease

Fernandez, A. M., Santi, A., & Aleman, I. T. (2018) · Brain Plasticity · doi:10.3233/bpl-180071 · Cited by 25

Role of the Insulin-like Growth Factor System in Neurodegenerative Disease

LEWITT, M. S., & Boyd, G. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084512 · Cited by 25

IGF-1 receptor regulates upward firing rate homeostasis via the mitochondrial calcium uniporter

Katsenelson, M., Shapira, I., Abbas, E., Jevdokimenko, K., Styr, B., Ruggiero, A., Aïd, S., Fornasiero, E. F., Holzenberger, M., Rizzoli, S. O., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121040119 · Cited by 23

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models

Arcos, J., Grünenwald, F., Sepúlveda, D., Jerez, C., Urbina, V., Huerta, T., Troncoso-Escudero, P., Tirado, D., Perez, A., Díaz‐Espinoza, R., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01734-1 · Cited by 24

Milk signalling in the pathogenesis of type 2 diabetes

Melnik, B. C. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2010.12.017 · Cited by 19

Down‐Regulation of Insulin Like Growth Factor 1 Involved in Alzheimer’s Disease via MAPK, Ras, and FoxO Signaling Pathways

Kang, K., Bai, J., Zhong, S., Zhang, R., Zhang, X., Xu, Y., Zhao, M., Zhao, C., & Zhou, Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8169981 · Cited by 20

Stem cell function and maintenance – ends that matter: Role of telomeres and telomerase

Saeed, H., & Iqtedar, M. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9346-3 · Cited by 19

Neuropeptide signaling and SKN-1 orchestrate differential responses of the proteostasis network to dissimilar proteotoxic insults

Boocholez, H., Marques, F. C., Levine, A., Roitenberg, N., Siddiqui, A. A., Zhu, H., Moll, L., Grushko, D., Bruck‐Haimson, R., Elami, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110350 · Cited by 18

Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment

Rauskolb, S., Andreska, T., Fries, S., von Collenberg, C. R., Blum, R., Monoranu, C., Villmann, C., & Sendtner, M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01352-5 · Cited by 17

Astrocytes Regulate the Expression of Insulin-Like Growth Factor 1 Receptor (IGF1-R) in Primary Cortical Neurons During In Vitro Senescence

Costantini, C., Lorenzetto, E., Cellini, B., Buffelli, M., Rossi, F., & Bianca, V. D. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9305-5 · Cited by 18

Aging, Protein Aggregation, Chaperones and Neurodegenerative Disorders: Mechanisms of Coupling and Therapeutic Opportunities

Cohen, E. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10088 · Cited by 17

Insulin Action in the Brain and the Pathogenesis of Alzheimer’s Disease

Kahn, C. R., & Suzuki, R. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0_1 · Cited by 17

Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders

Cohen, E., Moll, L., & Elami, T. (2014) · Swiss Medical Weekly · doi:10.4414/smw.2014.13917 · Cited by 15

AAV delivery of shRNA against IRS1 in GABAergic neurons in rat hippocampus impairs spatial memory in females and male rats

Sánchez‐Sarasúa, S., Ribes‐Navarro, A., Beltrán-Bretones, M. T., & Sánchez‐Pérez, A. M. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02155-x · Cited by 15

Growth Factor Receptor‐Bound Protein 10‐Mediated Negative Regulation of the Insulin‐Like Growth Factor‐1 Receptor‐Activated Signalling Pathway Results in Cognitive Disorder in Diabetic Rats

Ma, L., Wei, Q., Deng, H., Zhang, Q., Li, G., Tang, N., Xie, J., & Chen, Y. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12040 · Cited by 14

Differential Effects of Delayed Aging on Phenotype and Striatal Pathology in a Murine Model of Huntington Disease

Tallaksen‐Greene, S. J., Sadagurski, M., Zeng, L., Mauch, R. J., Perkins, M., Banduseela, V. C., Lieberman, A. P., Miller, R. A., Paulson, H. L., & Albin, R. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1830-14.2014 · Cited by 14

Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function

Cho, S. B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042211 · Cited by 12

Developing Trojan horses to induce, diagnose and suppress Alzheimer’s pathology

Aziz, A. A., & Amtul, Z. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104471 · Cited by 12

Lipid Assemblies at the Crossroads of Aging, Proteostasis, and Neurodegeneration

Roitenberg, N., & Cohen, E. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.09.003 · Cited by 12

CanToxoplasma gondiiPave the Road for Dementia?

Saftawy, E. A. E., Amin, N. M. A., Sabry, R. M., El‐Anwar, N., Shash, R. Y., Elsebaie, E. H., & Wassef, R. M. (2020) · Journal of Parasitology Research · doi:10.1155/2020/8859857 · Cited by 13

Using machine intelligence to uncover Alzheimer’s disease progression heterogeneity

Qorri, B., Tsay, M., Agrawal, A., Au, R., & Gracie, J. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00026 · Cited by 13

Presenilin Regulates Insulin Signaling via a γ-Secretase-independent Mechanism

Maesako, M., Uemura, K., Kuzuya, A., Sasaki, K., Asada, M., Watanabe, K., Andō, K., Kubota, M., Kihara, T., & Kinoshita, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248922 · Cited by 13

The change of circulating insulin like growth factor binding protein 7 levels may correlate with postoperative cognitive dysfunction

Jiang, J., Chen, Z., Liang, B., Yan, J., Zhang, Y., Xu, H., Huang, Y., & Jiang, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.046 · Cited by 12

Countering neurodegeneration by reducing the activity of the insulin/IGF signaling pathway: Current knowledge and future prospects

Cohen, E. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.032 · Cited by 13

Intravenous chaperone treatment of late-stage Alzheimer´s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes

Zhang, R., Ohshima, M., Brodin, D., Wang, Y., Morancé, A., Schultzberg, M., Chen, G., & Johansson, J. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03161-x · Cited by 11

Pathways to decoding the clinical potential of stress response FOXO-interaction networks for Huntington's disease: of gene prioritization and context dependence

Parmentier, F., Lejeune, F., & Néri, C. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00022 · Cited by 12

Irs2 deficiency alters hippocampus-associated behaviors during young adulthood

Tanokashira, D., Wang, W., Maruyama, M., Kuroiwa, C., White, M. F., & Taguchi, A. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.101 · Cited by 9

Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging

Zemva, J., Udelhoven, M., Moll, L., Freude, S., Stöhr, O., Brönneke, H. S., Drake, R. B., Krone, W., & Schubert, M. (2012) · AGE · doi:10.1007/s11357-012-9491-x · Cited by 11

Relative expression of the p75 neurotrophin receptor, tyrosine receptor kinase A, and insulin receptor in SH-SY5Y neuroblastoma cells and hippocampi from Alzheimer's disease patients

Ito, S., Ménard, M., Atkinson, T. G., Brown, L., Whitfield, J., & Chakravarthy, B. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.09.015 · Cited by 10

Insulin signaling in the aging of healthy and proteotoxically stressed mechanosensory neurons

Scerbak, C., Vayndorf, E. M., Parker, J. A., Néri, C., Driscoll, M., & Taylor, B. E. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00212 · Cited by 12

Reducing Igf-1r Levels Leads To Paradoxical and Sexually Dimorphic Effects in HD Mice

Corrochano, S., Renna, M., Osborne, G. F., Carter, S., Stewart, M. E., May, J., Bates, G. P., Brown, S. D. M., Rubinsztein, D. C., & Acevedo‐Arozena, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105595 · Cited by 10

New cellular and molecular approaches to ageing brain

Tripathi, A. (2012) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.190410 · Cited by 11

Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation

Hu, Y., Sun, Q., Zhang, W., Huo, Y.-J., Xu, C., & Liu, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0033-7 · Cited by 10

Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology

Zegarra-Valdivia, J. A., Fernandez, A. M., Martinez‐Rachadell, L., Herrero-Labrador, R., Fernandes, J., & Torres‐Alemán, I. (2022) · F1000Research · doi:10.12688/f1000research.121901.2 · Cited by 9

Proteostasis collapse, inter-tissue communication, and the regulation of aging at the organismal level

Dubnikov, T., & Cohen, E. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00080 · Cited by 9

Identification and Analysis of Components in Yizhi Granule and Cynomolgus Monkey Plasma after Oral Administration by UPLC/ESI-Q-TOF MS and Their Protective Effects on PC12 Cells

Hao, E., Qin, J., Wei, W., Miao, J., Xie, Y., Pan, X., Hangxuan, W., Xie, J., Fan, X., Du, Z., et al. (2020) · Journal of Analytical Methods in Chemistry · doi:10.1155/2020/5165631 · Cited by 9

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets

Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10

Central Insulin-like Growth Factor-1 Treatment Enhances Working and Reference Memory by Reducing Neuroinflammation and Amyloid Beta Deposition in a Rat Model of Sporadic Alzheimer’s Disease

Dunacka, J., Grembecka, B., Majkutewicz, I., & Wrona, D. (2025) · Pharmaceuticals · doi:10.3390/ph18040527 · Cited by 8

Mini-review: Retarding aging in murine genetic models of neurodegeneration

Albin, R. L., & Miller, R. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.014 · Cited by 8

Genetic Reduction of Insulin Signaling Mitigates Amyloid-β Deposition by Promoting Expression of Extracellular Matrix Proteins in the Brain

Sano, T., Ochiai, T., Nagayama, T., Nakamura, A., Kubota, N., Kadowaki, T., Wakabayashi, T., & Iwatsubo, T. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0071-23.2023 · Cited by 8

ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer’s Disease

Alves-Borba, L., Espinosa‐Fernández, V., Canseco-Rodríguez, A., & Sánchez‐Pérez, A. M. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230056 · Cited by 6

Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology

Zegarra-Valdivia, J. A., Fernandez, A. M., Martinez‐Rachadell, L., Herrero-Labrador, R., Fernandes, J., & Torres‐Alemán, I. (2022) · F1000Research · doi:10.12688/f1000research.121901.1 · Cited by 5

Contrasting consequences of podocyte insulin-like growth factor 1 receptor inhibition

Hurcombe, J., Barrington, F., Marchetti, M., Betin, V. M. S., Bowen, E. E., Lay, A. C., Ni, L., Dayalan, L., Pope, R. J. P., Brinkkoetter, P. T., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109749 · Cited by 5

Astrocytes at the intersection of ageing, obesity, and neurodegeneration

Firth, W., Pye, K. R., & Potter, P. G. W. (2024) · Clinical Science · doi:10.1042/cs20230148 · Cited by 6

Non-viability of crossing the Alzheimer mouse model Tg2576 with the type 2 diabetes mouse model ob/ob

Lubitz, I., Haroutunian, V. H., Katsel, P., LeRoith, D., Landa, N., Castel, D., Shaish, A., Ganor, R. S., & Beeri, M. S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.138 · Cited by 5

Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role

Tyagi, R., Vaidya, B., & Sharma, S. S. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00417-5 · Cited by 4

Gene deletion of Pregnancy-associated Plasma Protein-A (PAPP-A) improves pathology and cognition in an Alzheimer's disease mouse model

Bale, L. K., West, S. A., Gades, N. M., Baker, D. J., & Conover, C. A. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114976 · Cited by 4

Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology

Zegarra-Valdivia, J. A., Fernandez, A. M., Martinez‐Rachadell, L., Herrero-Labrador, R., Fernandes, J., & Torres‐Alemán, I. (2022) · F1000Research · doi:10.12688/f1000research.121901.3 · Cited by 4

The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer’s Disease

Horváth, A., Quinlan, P. S., Eckerström, C., Åberg, N. D., Wallin, A., & Svensson, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231026 · Cited by 4

Cognitive Impairment and the Diabetic Brain

Jellinger, K. A. (2015) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/2/2/1033 · Cited by 4

Diabetes and Alzheimer’s Disease

Takeda, S., & Morishita, R. (2017) · Springer eBooks · doi:10.1007/978-981-10-4376-5_8 · Cited by 6

Dietary restriction alters insulin signaling pathway in the brain

Todorovic, S. T., Simeunovic, V., Prvulović, M., Dakic, T. B., Jevdjovic, T. V., Sokanovic, S. J., Kanazir, S., & Mladenović, A. (2023) · BioFactors · doi:10.1002/biof.2018 · Cited by 4

Upregulation of Pin1 contributes to alleviation of cognitive dysfunction in diabetic mice

Qiu, D., Liu, T., & Qianping, W. (2023) · Brain and Behavior · doi:10.1002/brb3.3336 · Cited by 3

Nutrition and Dementia

Coppedè, F., Bosco, P., Fuso, A., & Troen, A. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/926082 · Cited by 5

Experience-Dependent Behavioral Plasticity in Avoiding Epigallocatechin Gallate (EGCG) Requires DAF-16/FOXO in the AIY Interneurons of Caenorhabditis elegans

Ishikawa, S., TAKEZAWA, Y., Iida, C., YAMADA, Y., CHIBA, K., Ali, M. S., Sun, S., & Kage‐Nakadai, E. (2024) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.70.164 · Cited by 4

Reduced IGF-1 signaling fails to limit Alzheimer’s disease progression in a novel rat model of IGF-1R haploinsufficiency

Narayan, S., Mao, K., Williams-Medina, A. R., Richmann, T., Gal, M., Engel, M., Zhang, Y., Graff, S., Sidoli, S., Barzilai, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-31601-1 · Cited by 2

Potential Therapeutic Strategies for Neurodegenerative Diseases

Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_9 · Cited by 2

Role of Central Insulin-Like Growth Factor-1 Receptor Signalling in Ageing and Endocrine Regulation

Moll, L., Zemva, J., & Schubert, M. (2011) · InTech eBooks · doi:10.5772/22924 · Cited by 1

The Novel Implication of Androgen in Diabetes-induced Alzheimer's Disease

Song, J., Jung, C., & Kim, O. Y. (2017) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2017.6.2.66 · Cited by 2

Genotype and Sex Differences in Longevity in Transgenic Mouse Models of Alzheimer’s Disease

Brown, R. E., Shin, S., Woodland, N., & Rae, E. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00042-7 · Cited by 2

Signal relay in C. elegans: A tissue-perspective on coordinating organismal proteostasis and its impact on aging

Cocciolone, L., Souparnika, A., Uvarova, V., Kessler, K., & van Oosten‐Hawle, P. (2025) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2025.100127 · Cited by 1

O1‐03‐08: Neuronal IGF‐1 resistance protects against premature death and reduces β‐Amyloid accumulation in Tg2576 mice

Hettich, M. M., Freude, S., Stöhr, O., Udelhoven, M., Krone, W., & Schubert, M. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.212

Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease

Stöhr, O., Schilbach, K., Moll, L., Hettich, M. M., Freude, S., Wunderlich, F. T., Ernst, M. B., Zemva, J., Brüning, J. C., Krone, W., et al. (2011) · AGE · doi:10.1007/s11357-011-9333-2 · Cited by 73

Neuronale IGF-1 Resistenz reduziert die β-Amyloid Akkumulation und schützt vor Alzheimer assoziierten Letalität in vivo

Hettich, M., Stöhr, O., Leeser, U., Udelhoven, M., Koch, L., Brüning, J., Krone, W., & Schubert, M. (2009) · Diabetologie und Stoffwechsel · doi:10.1055/s-0029-1221880

Role of neuronal IGF-1R signaling for the pathogenesis of Alzheimer's disease

Hettich, M. M. (2009) · Kölner Universitäts PublikationsServer (Universität zu Köln)

P2‐249: Neuronal insulin resistance reduces Alzheimer‐like pathology in Tg2576 mice independent of Foxo1 mediated transcription

Moll, L., Schilbach, K., Stöhr, O., Udelhoven, M., Zemva, J., Freude, S., Brüning, J. C., Krone, W., & Schubert, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1132